Akèy › Kansè Metastatik › Florid › Sarasota
Etid klinik pou Kansè Metastatik nan Sarasota, FL
19 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Sarasota (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Ap rekriteFaz 3
- Florida Cancer Specialists - South, Sarasota
A Study of ASP3082 in Adults With Advanced Solid Tumors
Ap rekriteFaz 1
- Florida Cancer Specialists & Research Institute Sarasota, Sarasota
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Florida Cancer Specialists, Sarasota
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Ap rekriteFaz 3
- Florida Cancer Specialists, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Ap rekriteFaz 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Ap rekriteFaz 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Clinical Study Site, Sarasota
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Florida Cancer Specialist, Sarasota
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Ap rekriteFaz 1/2
- Avenzo Therapeutics Recruiting Site, Sarasota
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Florida Cancer Specalists, Sarasota
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Ap rekriteFaz 1
- SCRI Florida Cancer Specialists - Sarasota, Sarasota
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1/2
- Florida Cancer Specialists, Sarasota
A Study of PYX-201 in Advanced Solid Tumors
Ap rekriteFaz 1
- SCRI - Florida Cancer Specialists, Sarasota
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Ap rekriteFaz 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
Ap rekriteFaz 1
- Florida Cancer Specialists - Sarasota, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Ap rekriteFaz 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Ap rekriteFaz 1
- Florida Cancer Specialists, Sarasota
Etid Kansè Metastatik nan lòt vil
- Houston, TX104 etid
- New York City, NY93 etid
- Nashville, TN70 etid
- Boston, MA63 etid
- Los Angeles, CA57 etid
- St. Louis, MO54 etid
- Arlington, VA53 etid
- Philadelphia, PA46 etid
- Chicago, IL45 etid
- San Antonio, TX44 etid
- Washington, DC43 etid
- Dallas, TX42 etid
Lòt etid nan Sarasota
- Kansè Poumon ki pa ti selil17 etid
- Kansè kolorektal16 etid
- Kansè ovè16 etid
- Kansè Endomèt14 etid
- Kansè nan tete12 etid
- Kansè (tout kalite)11 etid
- Kansè tete negatif triple8 etid
- Kansè poumon7 etid
- Kansè pankreyas7 etid
- Fibrilasyon atriyal7 etid
- Kansè pwostat6 etid
- Maladi fwa steatotik6 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.